Grail (NASDAQ:GRAL) Stock Price Down 6.7% – What’s Next?

Posted by Teresa Graham on Mar 11th, 2025

Grail, Inc. (NASDAQ:GRAL – Get Free Report) shares fell 6.7% during mid-day trading on Tuesday . The stock traded as low as $30.26 and last traded at $29.95. 571,661 shares changed hands during mid-day trading, a decline of 53% from the average session volume of 1,215,585 shares. The stock had previously closed at $32.09.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Wolfe Research assumed coverage on shares of Grail in a research report on Friday, November 15th. They set a “peer perform” rating on the stock. Morgan Stanley initiated coverage on Grail in a report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price target on the stock.

Read Our Latest Analysis on GRAL

Grail Stock Down 4.8 %

The business’s 50 day moving average price is $30.91 and its 200 day moving average price is $20.98.

Grail (NASDAQ:GRAL – Get Free Report) last posted its earnings results on Thursday, February 20th. The company reported ($1.86) EPS for the quarter, topping analysts’ consensus estimates of ($4.41) by $2.55. The company had revenue of $38.25 million during the quarter, compared to the consensus estimate of $35.33 million. On average, research analysts anticipate that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Institutional Trading of Grail

Hedge funds have recently bought and sold shares of the company. Alpha Wealth Funds LLC bought a new stake in shares of Grail during the 4th quarter valued at about $2,562,000. Ameriflex Group Inc. purchased a new position in shares of Grail in the fourth quarter worth approximately $95,000. PVG Asset Management Corp bought a new stake in Grail during the fourth quarter valued at approximately $398,000. Public Employees Retirement System of Ohio purchased a new stake in Grail during the fourth quarter valued at approximately $334,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new position in Grail in the fourth quarter worth approximately $1,201,000.

Grail Company Profile

(Get Free Report)

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.